knowledge -WSS

knowledge

author：comprehensive 2025-09-02 22:26:16 - browse：43369

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

These days, the surefire way to get ahead in health insurance is to become a health care provider, and Elevance just upped the ante. It’s joining with private equity to launch a $4 billion primary care company.

Elevance leaders divulged more about the company’s venture with Clayton, Dubilier & Rice on its first quarter earnings call Thursday. The partners announced the new company, yet unnamed, earlier this week, but the release was light on detail. The strategic partnership will house Elevance and CD&R’s doctors, clinics, and the technologies that help those doctors manage their patients.

Health insurers specialize in managing medical costs, and through ventures like this, they apply that expertise to managing patients’ chronic medical conditions. In arrangements like Medicare Advantage, where insurers are paid set amounts for members’ care, they’re incentivized to keep those patients healthy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

hotspot

WSS

Medicare Advantage coverage denials need scrutiny, senators say

How to address the problem of discarded donor organs

Profiling embryos to choose those with higher IQs is almost a reality

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Arena BioWorks launches in Cambridge to speed drug discovery

Congress gives doctors Medicare pay bump

knowledge

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

hotspot

Bright Health sells Medicare Advantage business to Molina

Kenai launches with $82 million for Parkinson’s stem cell therapy

Psychedelics group wrestles with new pharma identity

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

How to save PrEP access — and even expand it

How to fix the rural physician shortage in the U.S.

Wildfire smoke exposes gaps in outdoor worker protections

Ascension's ugly legal battle over care for poor patients in Texas

Activists slam private health insurers over coverage restrictions

Physician assistants need a new name. Here's what it should be

hotspot

Pfizer highlights cancer drugs it thinks could reignite investor interest

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Stories you might have missed in 2023: health, science, medicine

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Life science postdocs should get big pay hike, NIH panel says

hotspot

Wikipedia

hotspot

hotspot